However, there are no studies correlating serum FGF21 levels with heart failure after AMI during hospitalization in ST segment elevation myocardial infarction (STEMI) patients treated with emergency percutaneous coronary intervention (PCI). The gene discussed is FGF21; the disease is heart failure.